| |
Latest 10 SEC filings (by transaction date) for NKTR within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 14/24 | Deep Track Capital, LP | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Feb 22/24 | Feb 20/24 | Zalevsky Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -9,014 | $0.680 |
Feb 22/24 | Feb 20/24 | Wilson Mark Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -7,606 | $0.680 |
Feb 22/24 | Feb 20/24 | Robin Howard W | Direct Ownership | Common Stock | S - Open market or private sale | -20,033 | $0.680 |
Dec 15/23 | Dec 13/23 | Zalevsky Jonathan | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 250,000 | |
Dec 15/23 | Dec 13/23 | Wilson Mark Andrew | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 325,000 | |
Dec 15/23 | Dec 13/23 | Robin Howard W | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,300,000 | |
Nov 20/23 | Nov 17/23 | Zalevsky Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -9,646 | $0.490 |
Nov 20/23 | Nov 17/23 | Wilson Mark Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -7,179 | $0.490 |
Nov 20/23 | Nov 17/23 | Robin Howard W | Direct Ownership | Common Stock | S - Open market or private sale | -19,877 | $0.490 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for NKTR within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 14/24 | Mar 14/24 | Deep Track Capital, LP | Indirect Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Feb 22/24 | Feb 20/24 | Zalevsky Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -9,014 | $0.680 |
Feb 22/24 | Feb 20/24 | Wilson Mark Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -7,606 | $0.680 |
Feb 22/24 | Feb 20/24 | Robin Howard W | Direct Ownership | Common Stock | S - Open market or private sale | -20,033 | $0.680 |
Dec 15/23 | Dec 13/23 | Zalevsky Jonathan | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 250,000 | |
Dec 15/23 | Dec 13/23 | Wilson Mark Andrew | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 325,000 | |
Dec 15/23 | Dec 13/23 | Robin Howard W | Direct Ownership | Stock Option | A - Grant, award or other under Rule 16b-3(d) | 1,300,000 | |
Nov 20/23 | Nov 17/23 | Zalevsky Jonathan | Direct Ownership | Common Stock | S - Open market or private sale | -9,646 | $0.490 |
Nov 20/23 | Nov 17/23 | Wilson Mark Andrew | Direct Ownership | Common Stock | S - Open market or private sale | -7,179 | $0.490 |
Nov 20/23 | Nov 17/23 | Robin Howard W | Direct Ownership | Common Stock | S - Open market or private sale | -19,877 | $0.490 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Eyepoint Pharmaceuticals (OQ:EYPT) |
AbbVie (N:ABBV) |
Merck & Co (N:MRK) |